Edwards Looks To Smaller-Diameter Transcatheter Valve In 2010
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences hopes to overcome one of its biggest competitive disadvantages in the European transcatheter valve market early next year with the planned launch of a smaller-profile product
You may also be interested in...
Transcatheter Valve Data Gets Top-Line Attention At EuroPCR
Data from multiple registries presented last week at the EuroPCR conference in Paris offered no major trouble spots for European cardiologists looking to expand use of transcatheter aortic heart valves and U.S. doctors anxiously awaiting their approval
Transcatheter Valve Data Gets Top-Line Attention At EuroPCR
Data from multiple registries presented last week at the EuroPCR conference in Paris offered no major trouble spots for European cardiologists looking to expand use of transcatheter aortic heart valves and U.S. doctors anxiously awaiting their approval
Edwards: Surgical Valve Sales Slow As Transcatheter Valve Ramps Up
Growth in Edwards Lifesciences surgical heart valve sales slowed in the first quarter due in part to pricing missteps, while the firm's nascent transcatheter heart valve business continued to pick up steam